Abstract
The development of new products for the prevention and treatment of current as well as emerging and re-emerging diseases has led to the introduction of novel cell substrates in biologics. Examples include the demand for large-scale production of pandemic influenza vaccines and for therapeutic proteins, and the use of novel vectors for AIDS vaccines and in cancer gene therapy. A major safety issue regarding the use of novel cell substrates is adventitious agents, including viruses that may have been exogenously introduced due to cell passage history or indigenous viruses that are naturally occurring in the species of cell origin due to infection, or endogenous retroviruses that exist as a normal part of the host cell DNA. Additionally, in the case of genetically engineered cells, there is a concern for recombinant viruses that may be generated de novo involving vector virus sequences. Furthermore, potential oncogenicity of residual cellular DNA remains a theoretical safety concern related to tumorigenic cell substrates. This paper discusses safety issues related to novel cell substrates with a focus on tumorigenic cells and genetically engineered cells and presents the current testing recommendations for general cell substrate safety with details on additional assays for consideration in testing some novel cell substrates including tumorigenic cells.
- Novel cell substrates
- Viral vaccines
- Adventitious agents
- Latent viruses
- Endogenous retroviruses
- Chemical induction
- Tumorigenic cells
- DNA oncogenicity
- Cell banks
- End-of-production cells
- © PDA, Inc. 2010
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.